- Report
- April 2024
- 117 Pages
Global
From €2795EUR$3,160USD£2,413GBP
€3493EUR$3,950USD£3,016GBP
- Report
- July 2024
- 74 Pages
Global
From €2211EUR$2,500USD£1,909GBP
- Report
- July 2024
- 151 Pages
Global
From €3759EUR$4,250USD£3,245GBP
- Report
- December 2023
- 85 Pages
Global
From €3500EUR$4,240USD£3,128GBP
- Report
- January 2022
- 92 Pages
Global
From €3200EUR$3,876USD£2,860GBP
- Report
- October 2024
- 106 Pages
Global
From €3500EUR$4,240USD£3,128GBP
- Report
- August 2023
- 129 Pages
Global
From €3500EUR$4,240USD£3,128GBP
- Report
- July 2023
- 111 Pages
Global
From €3500EUR$4,240USD£3,128GBP
- Report
- July 2023
- 108 Pages
Global
From €3500EUR$4,240USD£3,128GBP
- Report
- May 2022
- 86 Pages
Global
From €3500EUR$4,240USD£3,128GBP
- Report
- March 2024
- 132 Pages
Global
From €840EUR$950USD£725GBP
The Needle Free Drug Delivery market is a subset of the Infusions and Injectables market, which focuses on the delivery of drugs and other therapeutic agents without the use of needles. This technology is designed to reduce the risk of infection and other complications associated with traditional needle-based delivery systems. Needle Free Drug Delivery systems typically use a variety of methods, such as jet injection, pressure-assisted delivery, and electroporation, to deliver drugs and other therapeutic agents. These systems are often used in the treatment of chronic diseases, such as diabetes, and can also be used to deliver vaccines and other medications.
Some of the companies in the Needle Free Drug Delivery market include Antares Pharma, Insulet Corporation, Valeritas, Inc., West Pharmaceutical Services, Inc., and Becton, Dickinson and Company. Show Less Read more